Related Experiment Video
Updated: Oct 30, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Long-term Outcome following Percutaneous Intervention of Intra-stent Coronary Occlusion and Evaluating the Different
Sandeep Basavarajaiah1, Satoru Mitomo2, Sunao Nakamura2
1Heartlands Hospital, University Hospitals Birmingham, United Kingdom.
Insights
This study investigated long-term outcomes of angioplasty for intra-stent chronic total occlusions (CTO). Drug-eluting stents (DES) and drug-coated balloons (DCB) showed better results than plain old balloon angioplasty (POBA) for target lesion revascularization and major adverse cardiac events.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Biology
Background:
- In-stent restenosis (ISR) angioplasty presents challenges with high recurrence rates.
- Intra-stent chronic total occlusions (CTO) have limited data regarding treatment outcomes.
- This study focuses on long-term clinical outcomes of angioplasty for intra-stent CTO.
Purpose of the Study:
- To explore long-term clinical outcomes after angioplasty for intra-stent CTO.
- To compare outcomes between percutaneous coronary intervention (PCI) with plain old balloon angioplasty (POBA), drug-eluting stents (DES), and drug-coated balloons (DCB).
Main Methods:
- A retrospective evaluation of 403 patients undergoing PCI for intra-stent CTO between 2011 and 2017.
- Patients were treated with POBA, DES, or DCB.
- Endpoints included cardiac death, TVMI, TLR, TVR, and MACE, with a median follow-up of 48 months.
Main Results:
- The study included 403 patients with a mean age of 69.2 years; 50% were diabetic, 38% had CKD.
- Overall MACE was 46%, with no significant differences in hard endpoints between POBA, DES, and DCB groups.
- Target lesion revascularization (TLR) and MACE were notably better in DCB and DES groups compared to POBA (TLR: 33% vs. 42% vs. 49%; MACE: 34% vs. 45% vs. 52%).
Conclusions:
- This is the first study to report very long-term outcomes following angioplasty for intra-stent CTOs.
- While hard endpoints were low, target lesion revascularization (TLR) rates remained high.
- Drug-eluting stents (DES) and drug-coated balloons (DCB) demonstrated superior outcomes compared to plain old balloon angioplasty (POBA).
Background:
Angioplasty for ISR remains a challenge with relatively high rates of recurrence. Although there is a plethora of data on ISR, there is relatively less data on intra-stent-CTO. In this study, we explore the long-term clinical outcomes following angioplasty to intra-stent CTO and study the differences in clinical outcomes between three treatment-arms: POBA vs. DES vs. DCB.
Methods And Results:
We evaluated all patients who underwent PCI to intra-stent CTO between 2011 and 2017. The endpoints used were: cardiac-death, TVMI, TLR, TVR, and MACE.During the study period, 403-patients with a mean age of 69.2 years had successful PCI to intra-stent CTO. 50% were diabetic, 38% had CKD and 32% had left ventricular dysfunction. 93% of cases were stable angina. 22% (n = 88) received only POBA, 28% (n = 113) received DCB and 50% (n = 202) received DES. During the median follow-up of 48-months, cardiac-death occurred in 5.8% (n = 23), TVMI in 4% (n = 16), TLR in 45.6% (n = 182), TVR in 48.7% (n = 194) and MACE of 46%. There were no differences in the hard endpoints between the 3treatment arms. However, the TLR and overall MACE were better in DCB and DES-groups as compared to POBA (TLR: 33%vs.42%vs.49%; p = 0.06); MACE (34% vs. 45% vs. 52%; p = 0.05).
Conclusion:
This is the first study that has focussed on the outcomes following angioplasty to intra-stent CTOs with a very long-term follow-up. The hard endpoints were low, although the TLR rates were high. In regards to treatment strategy, the DCB and DES provide relatively better outcomes than POBA.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Angina IV: Management

